Adagene Inc.

NASDAQ:ADAG

Biotechnology

Healthcare
$2.01 +3.68%

+$0.13 today

Market cap
$75.67M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$0.47
52W Low $1.30High $4.75

Volume 1.18M

Average 0.21M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$15.66M

FY 2025 · Annual

Investing Cash Flow

$476,803.00

FY 2025 · Annual

-57.0% YoY

Financing Cash Flow

$4.45M

FY 2025 · Annual

+17.9% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(73.18M)(79.97M)(18.95M)(33.42M)(17.61M)
Depreciation & Amortization1.13M1.45M1.21M926.25K589.79K
Deferred Income Tax622.43K(44.16K)000
Stock-Based Compensation18.68M10.52M7.27M4.91M3.74M
Change in Working Capital9.35M21.94M(16.55M)(1.89M)(775.3K)
Accounts Receivables(3M)6.89M397.41K213.72K(9.04K)
Inventory6.02M0000
Accounts Payables1.51M344.51K(572.37K)1.15M(1.36M)
Other Working Capital4.82M14.75M(16.38M)(3.25M)591.01K
Other Non-Cash Items(9.95K)(2.5M)(1.44M)(222.24K)(1.6M)
Operating Cash Flow(43.41M)(48.61M)(28.45M)(29.7M)(15.66M)
Capital Expenditures(2.51M)(690.94K)(85.01K)(33.58K)(17.05K)
Acquisitions (Net)00000
Purchases of Investments00(47M)(128.5M)(80M)
Sales of Investments0047M129.64M80.49M
Other Investing Activities04.89K7.66K1691.4K
Investing Cash Flow(2.51M)(686.05K)(77.36K)1.11M476.8K
Debt Repayment(702.86K)21.48M(5.37M)(3.42M)(12.24M)
Common Stock Issued149.79M05.5K7.33M138.28K
Common Stock Repurchased(2.36M)(3.98M)000
Dividends Paid00000
Other Financing Activities(1.37M)323.21K5.5K(137.3K)0
Financing Cash Flow145.36M17.82M(5.37M)3.77M4.45M
Effect of Forex Changes(192.35K)842.2K74.72K81.88K64.55K
Net Change in Cash99.24M(30.63M)(33.82M)(24.74M)(10.67M)
Free Cash Flow(45.92M)(49.3M)(28.54M)(29.73M)(15.67M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$17.6M
+ D&A$589.8K
+ Stock-Based Comp$3.7M
+ Deferred Tax$0
- Working Capital-$775.3K
- Other Non-Cash-$1.6M
= Operating Cash Flow-$15.7M
- Capex-$17.1K
= Free Cash Flow-$15.7M

Analysis

FY2025 free cash flow is -$15.7M. FCF conversion is 89.0% of net income. Operating cash flow was -$15.7M, with capex of -$17.1K. The largest bridge item is Stock-Based Comp at $3.7M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 9, 2026
4Statement of changes in beneficial ownershipOct 2, 2026
4Statement of changes in beneficial ownershipSep 25, 2026
6-K6-K filingSep 25, 2026
6-K6-K filingSep 22, 2026

Does ADAG generate free cash flow?

Adagene Inc. (ADAG) generated -$15.67M of free cash flow in fiscal 2025.

How much operating cash flow does ADAG produce?

Operating cash flow was -$15.66M, before capital expenditures of $17,053.00.